Ashwath Jayagopal - Feb 12, 2024 Form 4 Insider Report for Ocuphire Pharma, Inc. (OCUP)

Role: Chief Scientific & Dev. Ofc.
Signature: /s/ Amy Rabourn, by Power of Attorney
Stock symbol: OCUP
Transactions as of: Feb 12, 2024
Transactions value $: $0
Form type: 4
Date filed: 2/14/2024, 06:35 PM
Next filing: May 24, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OCUP	Common Stock	Award	$0	+75K		$0.00	75K	Feb 12, 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OCUP	Employee Stock Option (right to buy)	Award	$0	+225K		$0.00	225K	Feb 12, 2024	Common Stock	225K	$2.66	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of February 12, 2024, subject to the Reporting Person's continuing service.
F2	The option will vest with respect to 25% on February 12, 2025, with the remaining shares vesting quarterly in 12 equal installments thereafter, subject to the Reporting Person's continuing service.